To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Aim: To compare outcomes for patients accepted and rejected for SABR who were presented in 2012 with those presented in 2015 at the central MDT. To access this article, please choose from the options below Purchase access to this article Claim Access If you are a current subscriber with Society Membership or an Account Number, claim your access now.